Indeed, IL-17 was significantly increased in the sera of NASH patients compared with control and this increase was more pronounced in the serum of fibrotic patients with NASH; this confirms the role of IL-17 in liver diseases [5]. The gene discussed is IL17A; the disease is metabolic dysfunction-associated steatohepatitis.